Health TrialsbyHealthPanel

Effects of Nonpharmacological Interventions in Sleep Quality, Anxiety, and Delirium for Patients of Adult Intensive Care Units

ConditionsIntensive Care UnitCritical CareSleep QualityAnxietyDelirium
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChiayi Christian Hospital

About this trial

This study will investigate the effect of nonpharmacological intervention in sleep quality, anxiety and delirium among adult ICU patients.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Conscious and able to speak or write (GCS ≥ 11)

Hemodynamically stable

Normal hearing and able to communicate in a low voice

Stay in ICU for more than 24 hours

Disqualifiers

Pre-existing insomnia diagnosis with long-term reliance on sleep medication,

Sleep-related medical history such as sleep apnea

Shift work prior to hospitalization

Diagnosis of alcohol abuse or schizophrenia

Trial design

Design model

Parallel

Treatments tested in this trial

  • music combined with lavender essential oil group

    Device

    listening of 30 mins ocean wave music, aromatherapy of lavender essential oil, and eye masks and earplugs.

Treatment groups

154 Participants
are divided into 2 treatment groups
Group A: music combined with lavender essential oil groupExperimental treatment 1 intervention
Group B: routine careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Sleep Quality1

The investigator records the sleep quality using Richards-Campbell sleep scale

Time frame
To record the sleep quality at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.
2

Sleep Quality2

The investigator records the sleep quality using Verran sleep scale

Time frame
To record the sleep quality at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.
3

Anxiety1

The investigator records the degree of anxiety using the spielberger state- trait anxiety inventory

Time frame
To record the anxiety at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.
4

Anxiety2

The investigator records the degree of anxiety using the Visual analogue scale.

Time frame
To record the anxiety at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chiayi Christian Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: